天天干天天日天天操_日韩裸体无遮挡免费视频_东京热一本到无码_aⅴ无码天堂av

  Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory
 
logn  

username:

 password:

 

  home
 
  Products Center
  API
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Cabazitaxel
Irinotecan HCl Trihydrate 99.5%
Etoposide USP31
Palonosetron Hydrochloride
  N-1 stage of Paclitaxel and Docetaxel
7-Troc-Paclitaxel
7,10-di-Troc-Docetaxel
more...
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
more...
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
Ethyl (2R,3S)-3-Phenylisoserine Ester
more...
 
Your location:Home>>R & D >>Patents
 
 

Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns three patents as below:

 One of Irinotecan’s Intermediates & its Preparation method and preparation Method Of Irinotecan
Patent Number: ZL 2007 1 004 1525.X
Issue Date: Oct. 27, 2010

 A Synthetic method of Docetaxel
Patent Number: ZL 2006 1 0116735.6
Issue Date: 30 July, 2008

 A method of irinotecan hydrochloride
Patent Number: ZL2016 1 1234299.2
Issue Date: 8 March, 2019


Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.


 
CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE